Attention Investors : Prevent Unauthorized Transactions in your Trading / demat account -->Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. Update your Mobile Number & e mail id with your Broker / Depository Participant. Receive alerts on your Registered Mobile for all Transactions / debit and other important transactions in your Trading / demat account directly from Exchanges & CDSL on the same day. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month......... Issued in the interest of investors. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. SCORES - Filing compliant on SCORES – Easy & quick    a. Register on SCORES portal.    b. Mandatory details for filing complaints on SCORES : Name, PAN, Address, Mobile Number, Email ID.    c. Benefits : Effective communication . Speedy redressal of the grievances Website : https://scores.sebi.gov.in/ Head Office / ARN Desk Backoffice Employee Sub-Broker/Sale Manager Branch Client Quotes NAV Insurance NAV

ipo  IPO Forthcoming IPO's Open / Current IPO's Closed IPO's New Issue Monitor New Listing Basis of Allotment Draft Prospectus Best Performers IPO News Know IPO's / FAQ's Equities | Mutual Funds | Commodities | Derivatives | IPO | Insurance Products & Services    >   IPO   >   Synopsis Details Mahamaya Lifesciences Ltd Registered Office:    #DPT-033 Gr Flr Plt #79-80 DLF ,   Prime Tower F Blo.Okhla Phase1 ,   New Delhi - 110020 ,   New Delhi , India.   Phone: +91-11 4656 1474   Fax: cs@mahamayalifesciences.com   Website:https://www.mahamayalifesciences.com/ Initial public offer of up to 61,78,800* equity shares of face value of Rs. 10/- each ("Equity shares") of Mahamaya Lifesciences Limited ("MLL" or the "Company") for cash at price of Rs. [*] per equity share (including a share premium of [*] per equity share) (the "Offer Price"), aggregating up to Rs. [*] Crore ("the Offer"), comprising a fresh offer of upto 56,38,8008* equity shares aggregating to Rs. [*] Crore (the "Fresh Offer") and an offer for sale of upto 540,000* equity shares (the "Offered Shares") of face value of Rs. 10/- each aggregating up to Rs. [*] Crore ("offer for sale") comprising of 3,70,000* equity shares aggregating up to Rs. [*] Crore by Krishnamurthy Ganesan and 1,70,000* equity shares aggregating up to Rs. [*] Crore by Lalitha Krishnamurthy (collectively reffered to as the "Selling Shareholders") out of which 3,09,600 equity shares of face value Rs. 10/- each, at an offer price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the offer (the "Market Maker Reservation Portion"). The offer less market maker reservation portion i.e. net offer of 58,69,200* equity shares of face value of Rs. 10/- each, at an offer price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores is hereinafter referred to as the "Net Offer". The offer and net offer will constitute 26.40% and 25.08% respectively of the post-offer paid-up equity share capital of the company. Price Band: Rs. 108 to Rs. 114 per equity share of face value Rs. 10 each. The floor price is 10.8 times of the face value of the equity shares and the cap price is 11.4 times of the face value of the equity shares. Bids can be made for minimum of 2,400 equity shares and in multiples of 1,200 equity shares thereafter. Issue Money Payable On Opens On Closes On Application Allotment 11-Nov-25 13-Nov-25 Rs 108.00-114.00 Rs 0.00-0.00 Minimum Application for shares in Nos : 2400   Further Multiples of : 1200 Mahamaya Lifesciences Ltd   Rs Cr Lead Managers to the Issue Project Cost 0.00 Oneview Corporate Advisors Pvt Ltd Project Financed through Current Offer 66.73   Post Issue Equity Share Capital 23.41   Issue Price Rs. 108.00   Projects Funding capital expenditure towards setting up of a new technical manufacturing plant Construction of warehouse building and purchase of machinery Promoted By Krishnamurthy Ganesan Lalitha Krishnamurthy Prashant Krishnamurthy Listing At BSE - SME Registrar to the Issue                SEBI Common Reg. No. INZ000206338          MAPIN NO:10014845        CDSL : IN-DP-CDSL-291-2005 MERCHANT BANKING REGISTRATION NO : NM000011575 Terms of the Site   I   Privacy Policy   I  Disclaimer   I  Broker Norms   I  Attention and Advisory for Investors   I  Investor Relations   I  Investor Charter   I  Site Map   I  Payment Gateway   I  Circular   I  Upfront Margin   I  Pricing   I  Investor Complaints   I  Depository Participant   I  Investor Complaints for DP   I  CDSL E-Voting   I  Maintenance of Website   I   Details of authorized persons   I   SMART ODR   I   Bank Details   I   View Client Collateral Details   I   Online KYC Closure INTERNAL CONTROL POLICY  I  AML POLICY  I  RMS POLICY  I  POLICIES & PROCEDURES  I  CLIENT ACCEPTANCE POLICY   I   CLIENT REGISTRATION FORM KYC Form Mandatory Document   I   DOCUMENTS IN VERNACULAR LANGUAGES BSE  I  NSE  I  CDSL  I  SEBI  I  MCX  I  NCDEX © 2010 SHARE MART. All rights reserved Designed, Developed and Content provided by CMOTS Infotech ( ISO 9001:2015 certified )